Orphan Drugs: Making Rare Disease Rarer
Orphan Drugs: Making Rare Disease Rarer
Type:
Video
From the 15th Annual BIO CEO & Investor Conference at the Waldorf Astoria Hotel in New York on February 12th, 2013.
The signing of FDASIA by President Obama in July reinforces the country's commitment to fostering innovation for rare diseases. With a record 460 medicines in late-stage clinical trials, biopharmaceutical companies have embraced rare disease medicine and are rapidly developing the pipeline with hopes of achieving the ever elusive blockbuster drug.
February 12, 2013
|
February 12, 2013
|
February 12, 2013
|
February 8, 2013
|
February 7, 2013
|
January 21, 2013
|
December 20, 2012
|
September 18, 2012
|
